Supplementary Table 1 from A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Autor: Ian D. Lewis, Dale Song, Pierre Fustier, Patrick Hagner, Anjan Thakurta, Jacqueline Russo, Chih-Jian Lih, P. Mickey Williams, Yandan Yang, Louis M. Staudt, George W. Wright, Pier Luigi Zinzani, Thomas E. Witzig, Gilles Salles, Francisco J. Hernandez-Ilizaliturri, David A. Eberhard, Pierre Brousset, Graham W. Slack, Randy D. Gascoyne, Nina Wagner-Johnston, Kim M. Linton, Simon Rule, Andrew Davies, Marek Trněný, Myron S. Czuczman
Rok vydání: 2023
DOI: 10.1158/1078-0432.22467816.v1
Popis: Investigator's Choice (IC) Dosing Regimens
Databáze: OpenAIRE